MedPath

Midamarc

Brand Name: Midamarc

Generic Name: Midazolam

Active
Registration Number

DR-XY48703

Dosage Form

Solution for Injection (IM/IV/Rectal)

Issuance Date

April 14, 2023

Expiry Date

April 14, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL (15 mg/3 mL)
PackagingType I colorless glass ampoule x 3 mL (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

MidazolamActive
Monograph: Midazolam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform